http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102389111-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56922 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2020-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102389111-B1 |
| titleOfInvention | Composition for predicting or diagnosing early stage diffuse gastric cancer comprising measuring agent of the level of pepsinogen II |
| abstract | The present invention discovers pepsinogen II as a biomarker for predicting or diagnosing early diffuse gastric cancer, and provides compositions, kits and information capable of predicting or diagnosing early diffuse gastric cancer according to the level of pepsinogen II measured in a subject To a method, the composition, kit and information providing method according to an aspect of the present invention can predict or diagnose early diffuse gastric cancer with high sensitivity and specificity if the level of serum pepsinogen II is 20 μg/L or more, and further A preparation capable of measuring the level of serum pepsinogen II as it is possible to classify the risk of a subject for early diffuse gastric cancer based on whether the level of serum pepsinogen II is 20 μg/L or more and whether the Helicobacter pylori status is positive , or together with a composition and kit containing a formulation capable of detecting the Helicobacter pylori (HP) state, and a method for providing information using the same, have an excellent effect that can be usefully utilized as a non-invasive means that can be performed before endoscopy . |
| priorityDate | 2020-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.